An extension study of JR-031 in infants with neonatal hypoxic ischemic encephalopathy (hereinafter referred to as nHIE) for which hypothermia therapy is indicated
Phase 1
- Conditions
- neonatal hypoxic ischemic encephalopathy (nHIE)
- Registration Number
- JPRN-jRCT2033200293
- Lead Sponsor
- Yamamoto Tatsuyoshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
An infant whose parent (legal representative) provides written informed consent
Exclusion Criteria
An infant who, in the opinion of the investigator or subinvestigator, is not appropriate for the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method